RegentAtlantic Capital’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $5.24M | Sell |
86,255
-4,300
| -5% | -$275K | 0.16% | 101 |
|
|
2022
Q2 | $5.69M | Sell |
90,555
-322
| -0.4% | -$21.3K | 0.19% | 95 |
|
|
2022
Q1 | $6.39M | Sell |
90,877
-1,277
| -1% | -$86.3K | 0.18% | 96 |
|
|
2021
Q4 | $5.76M | Sell |
92,154
-3,983
| -4% | -$250K | 0.16% | 106 |
|
|
2021
Q3 | $5.93M | Sell |
96,137
-3,400
| -3% | -$205K | 0.18% | 96 |
|
|
2021
Q2 | $5.96M | Sell |
99,537
-3,058
| -3% | -$194K | 0.18% | 94 |
|
|
2021
Q1 | $6.24M | Sell |
102,595
-5,283
| -5% | -$292K | 0.21% | 89 |
|
|
2020
Q4 | $5.07M | Sell |
107,878
-9,167
| -8% | -$397K | 0.2% | 93 |
|
|
2020
Q3 | $4.35M | Sell |
117,045
-45,913
| -28% | -$1.74M | 0.2% | 100 |
|
|
2020
Q2 | $5.95M | Sell |
162,958
-49,055
| -23% | -$1.71M | 0.33% | 65 |
|
|
2020
Q1 | $6.48M | Sell |
212,013
-8,767
| -4% | -$389K | 0.5% | 47 |
|
|
2019
Q4 | $11.3M | Sell |
220,780
-5,426
| -2% | -$262K | 0.68% | 33 |
|
|
2019
Q3 | $10.7M | Buy |
226,206
+62,294
| +38% | +$2.97M | 0.7% | 32 |
|
|
2019
Q2 | $8.14M | Buy |
163,912
+13,509
| +9% | +$635K | 0.55% | 45 |
|
|
2019
Q1 | $6.4M | Buy |
150,403
+17,846
| +13% | +$789K | 0.45% | 61 |
|
|
2018
Q4 | $5.44M | Buy |
132,557
+2,334
| +2% | +$100K | 0.46% | 64 |
|
|
2018
Q3 | $6.08M | Buy |
130,223
+2,162
| +2% | +$98.8K | 0.47% | 61 |
|
|
2018
Q2 | $5.58M | Buy |
128,061
+5,524
| +5% | +$258K | 0.48% | 56 |
|
|
2018
Q1 | $5.62M | Sell |
122,537
-609
| -0.5% | -$29.5K | 0.47% | 63 |
|
|
2017
Q4 | $6.23M | Sell |
123,146
-8,993
| -7% | -$474K | 0.51% | 54 |
|
|
2017
Q3 | $6.87M | Sell |
132,139
-26,975
| -17% | -$1.31M | 0.59% | 47 |
|
|
2017
Q2 | $7.79M | Sell |
159,114
-16,672
| -9% | -$773K | 0.71% | 42 |
|
|
2017
Q1 | $8.28M | Sell |
175,786
-27,213
| -13% | -$1.3M | 0.77% | 38 |
|
|
2016
Q4 | $9.75M | Sell |
202,999
-4,717
| -2% | -$216K | 0.95% | 27 |
|
|
2016
Q3 | $8.22M | Sell |
207,716
-23,547
| -10% | -$885K | 0.85% | 32 |
|
|
2016
Q2 | $8.21M | Sell |
231,263
-9,233
| -4% | -$360K | 0.79% | 31 |
|
|
2016
Q1 | $9.42M | Sell |
240,496
-21,956
| -8% | -$821K | 1.04% | 21 |
|
|
2015
Q4 | $11.3M | Buy |
262,452
+9,035
| +4% | +$397K | 1.21% | 19 |
|
|
2015
Q3 | $10.6M | Sell |
253,417
-2,924
| -1% | -$137K | 1.02% | 23 |
|
|
2015
Q2 | $12.8M | Buy |
256,341
+12,747
| +5% | +$604K | 1.14% | 21 |
|
|
2015
Q1 | $11M | Buy |
243,594
+23,427
| +11% | +$1.05M | 0.96% | 24 |
|
|
2014
Q4 | $10.6M | Buy |
220,167
+13,419
| +6% | +$638K | 0.9% | 25 |
|
|
2014
Q3 | $9.9M | Buy |
206,748
+35,061
| +20% | +$1.7M | 0.93% | 24 |
|
|
2014
Q2 | $8.5M | Buy |
171,687
+3,407
| +2% | +$159K | 0.79% | 28 |
|
|
2014
Q1 | $7.92M | Buy |
168,280
+2,545
| +2% | +$117K | 0.77% | 33 |
|
|
2013
Q4 | $7.96M | Sell |
165,735
-1,919
| -1% | -$86K | 0.77% | 33 |
|
|
2013
Q3 | $7.01M | Sell |
167,654
-4,673
| -3% | -$201K | 0.77% | 33 |
|
|
2013
Q2 | $7.03M | Buy |
+172,327
| New | +$6.34M | 0.83% | 26 |
|
Other funds holding MET
RegentAtlantic Capital's MET Position: Q3 2022 in Review
RegentAtlantic Capital reduced its MetLife (MET) stake by 4.7% in Q3 2022, selling an estimated $275K and leaving 86,255 shares worth $5.24M. The position accounts for 0.16% of the portfolio, ranked #101.
RegentAtlantic Capital first reported a position in MET in Q2 2013 and has held it in 38 quarters since. The position peaked at $12.8M in Q2 2015. 1,194 funds tracked by Wall St. Rank hold MET as of Q3 2022.
- RegentAtlantic Capital held 86,255 shares of MetLife worth $5.24M as of Q3 2022.
- RegentAtlantic Capital sold 4,300 MetLife shares in Q3 2022, an estimated $275K.
- MetLife made up 0.16% of RegentAtlantic Capital's portfolio in Q3 2022, its #101 holding.
- RegentAtlantic Capital first reported a position in MetLife in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's MetLife position peaked at $12.8M in Q2 2015.
- 1,194 funds tracked by Wall St. Rank held MetLife as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.